4.7 Article

Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Infectious Diseases

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

Ali Rostami et al.

Summary: The study revealed significant variations in SARS-CoV-2 seroprevalence among different geographic regions, possibly related to income levels, human development indices, geographic latitudes, and climates. It was estimated that approximately 263.5 million individuals had been exposed or infected globally by 2020.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Infectious Diseases

Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis

Wan Yang et al.

Summary: This study estimated the infection-fatality risk of COVID-19 in New York City, showing that the risk for individuals aged 65 and above is significantly higher than younger age groups.

LANCET INFECTIOUS DISEASES (2021)

Review Biology

Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19

N. Kronfeld-Schor et al.

Summary: This article explores the uncertainty of COVID-19 becoming a seasonal disease by observing the variations in infectious diseases across seasons. Combining insights from epidemiology, physiology, and animal studies, it highlights the potential impact of host immune seasonality, weather, and human behavior on the seasonality of COVID-19 while stressing the need for further research.

JOURNAL OF BIOLOGICAL RHYTHMS (2021)

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Multidisciplinary Sciences

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Lewis F. Buss et al.

Summary: Research indicates that the attack rate of COVID-19 in Manaus, the capital of Amazonas state in northern Brazil, reached 66% in June 2020, rising to 76% by October, higher than the estimated attack rate of 29% in Sao Paulo, southeastern Brazil, during the same period.

SCIENCE (2021)

Article Infectious Diseases

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020

Anna Jeffery-Smith et al.

Summary: The study found that individuals who had prior exposure to SARS-CoV-2 had a significantly lower risk of re-infection after a second outbreak in two care homes in London. The protection offered by prior infection against re-infection was estimated to be around 96%, based on different statistical models.

EUROSURVEILLANCE (2021)

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Editorial Material Medicine, General & Internal

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Ester C. Sabino et al.

LANCET (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19

Jun Wu et al.

Summary: The study quantified IgM and IgG antibodies recognizing SARS-CoV-2 in 349 symptomatic COVID-19 patients over 6 months, showing that IgM levels dropped after 3 months while IgG responses contracted but remained high at 6 months.

NATURE COMMUNICATIONS (2021)

Letter Immunology

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection

Pyoeng Gyun Choe et al.

Summary: The kinetics of SARS-CoV-2 neutralizing antibodies were investigated in asymptomatic individuals and pneumonia patients, showing a decline in antibody titer from 219.4 at 2 months to 143.7 at 5 months after infection, indicating a waning antibody response.

EMERGING INFECTIOUS DISEASES (2021)

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Allergy

SARS-CoV-2 antibody testing-questions to be asked

Mustafa K. Oezcueruemez et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Abishek Chandrashekar et al.

SCIENCE (2020)

Editorial Material Infectious Diseases

The important role of serology for COVID-19 control

Amy K. Winter et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

Article Health Care Sciences & Services

Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer

Monica Gandhi et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques

Wei Deng et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Corine H. GeurtsvanKessel et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Seasonal coronavirus protective immunity is short-lasting

Arthur W. D. Edridge et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Leo Hanke et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Ann-Sofie Rudberg et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands

Ed Slot et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

Daniel Stadlbauer et al.

NATURE (2020)

Article Cell Biology

Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells

Monica Bodogai et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Medicine, General & Internal

Pregnancy and Infection

Athena P. Kourtis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

B cells and aging: molecules and mechanisms

Michael P. Cancro et al.

TRENDS IN IMMUNOLOGY (2009)

Article Immunology

Duration of antibody responses after severe acute respiratory syndrome

Li-Ping Wu et al.

EMERGING INFECTIOUS DISEASES (2007)

Article Immunology

Emerging infections and pregnancy

Denise J. Jamieson et al.

EMERGING INFECTIOUS DISEASES (2006)